严重慢性缺血性二尖瓣反流二尖瓣置换的瓣膜选择:长期随访
该研究对比严重缺血性二尖瓣反流患者使用生物瓣与机械瓣行二尖瓣置换的短期和长期结局。2000至2016年共424例患者,生物瓣188例(44%),机械瓣236例(56%),采用倾向评分匹配和逆概率加权分析。结果显示两组住院死亡和长期生存相似,但机械瓣组因心血管原因再入院(包括卒中和非神经性出血)更频繁。
要点
- 机械瓣与生物瓣在严重缺血性二尖瓣反流患者中长期生存无差异。
- 机械瓣组因心血管原因再入院风险增加,包括卒中和非神经性出血。
- 瓣膜类型未独立影响全因死亡率(HR 1.01)。
核心结论
- 瓣膜类型对严重缺血性二尖瓣反流行二尖瓣置换患者的长期生存无影响。
- 机械瓣可能增加神经事件和严重出血风险。
研究设计与样本
- 回顾性队列研究,2000至2016年单中心424例因严重缺血性二尖瓣反流行二尖瓣置换的患者。
- 生物瓣188例(44%),机械瓣236例(56%),采用1:1倾向评分匹配(每组126例)和逆概率加权比较组间差异。
主要发现
- 倾向评分匹配和逆概率加权队列中,两组住院死亡和早期术后不良事件相似。
- 5年和9年总体长期生存相似。
- 机械瓣组因心血管原因再入院(包括卒中和非神经性出血)更频繁(所有P值< .004)。
- 瓣膜类型未独立影响全因死亡率(HR 1.01;95%CI 0.71-1.43;P = .959)。
- 匹配患者中机械瓣与心血管事件再入院风险增加相关(HR 1.65;95%CI 1.17-2.32;P = .004)。
临床怎么用
- 对于严重缺血性二尖瓣反流行二尖瓣置换的患者,选择生物瓣或机械瓣应权衡长期生存相似但机械瓣增加再入院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prosthetic choice for mitral valve replacement is generally driven by patient age and patient and surgeon preference, and current guidelines do not discriminate between different etiologies of mitral valve disease. Our objective was to assess and compare short- and long-term outcomes after mitral valve replacement among patients with biological or mechanical prostheses in the setting of severe ischemic mitral regurgitation. METHODS: Between 2000 and 2016, 424 patients underwent mitral valve replacement for severe ischemic mitral regurgitation at our institution, using biological prosthesis in 188 (44%) and mechanical prosthesis in 236 (56%). A 1:1 propensity score match (n = 126 per group) and inverse probability of treatment weighting were used to compare groups. Short-term outcomes included in-hospital mortality and other cardiovascular adverse events. Long-term outcomes included survival and hospital readmission for cardiovascular causes, stroke, and major bleeding. RESULTS: In-hospital mortality and early postoperative adverse events were similar between groups in the propensity score match and inverse probability of treatment weighting cohorts. Overall long-term survival was similar at 5 and 9 years, but mechanical prosthesis recipients were more frequently readmitted to hospital for cardiovascular causes, including stroke and non-neurological bleeding in propensity score matching and inverse probability of treatment weighting analyses (all P values < .004). Type of prosthesis did not independently influence all-cause mortality (hazard ratio, 1.01; 95% confidence interval, 0.71-1.43; P = .959), but placement of a mechanical prosthesis was associated with increased risk of readmission for cardiovascular events (hazard ratio, 1.65; 95% confidence interval, 1.17-2.32; P = .004) among matched patients. CONCLUSIONS: The type of prosthesis has no influence on long-term survival among patients with severe ischemic mitral regurgitation undergoing mitral valve replacement. There may be an increased risk of neurologic events and serious bleeding associated with mechanical prostheses.
引用
- Bernard J, Kalavrouziotis D, Marzouk M, et al. Prosthetic choice in mitral valve replacement for severe chronic ischemic mitral regurgitation: Long-term follow-up. J Thorac Cardiovasc Surg. 2021. PMID: 33674062. doi:10.1016/j.jtcvs.2021.01.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。